SNATCH & THATCH LTD
Company number SC706187 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
SNATCH & THATCH LTD - Analysis Report
Company Number: SC706187
Analysis Date: 2025-07-19 12:32 UTC
Financial Health Assessment for SNATCH & THATCH LTD (as of 31 August 2023)
1. Financial Health Score: D
Explanation:
The company exhibits significant financial distress indicators, particularly in liquidity and solvency. Persistent negative net current assets and shareholders' funds position the company in a precarious financial state, warranting a cautious outlook and immediate remedial action.
2. Key Vital Signs
| Metric | 2023 Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 36,824 | Stable long-term investment in assets; slight growth from previous years. |
| Current Assets | 49,645 | Low level of liquid and short-term assets compared to liabilities; modest increase from 2022. |
| Current Liabilities | 167,107 | Substantial short-term debts, increased sharply from prior year; stresses liquidity. |
| Net Current Assets (Working Capital) | -117,462 | Negative and declining; company cannot cover short-term obligations with short-term assets. |
| Total Assets Less Current Liabilities | -80,638 | Negative net asset position; liabilities exceed assets, indicating insolvency on a balance sheet basis. |
| Shareholders' Funds (Equity) | -80,638 | Negative equity; accumulated losses exceed invested capital, a symptom of financial distress. |
| Average Number of Employees | 2 | Small workforce consistent with micro-entity status; limited operational scale. |
3. Diagnosis: Financial Condition and Symptoms Analysis
Liquidity Crisis (Symptoms of Distress): The company has a pronounced current liabilities burden (£167k) far exceeding current assets (£49k), resulting in a net current liability position of -£117k. This suggests an inability to meet short-term debts as they fall due, akin to a patient with low blood pressure struggling to maintain vital functions.
Solvency Issues (Underlying Condition): Negative shareholders' funds of -£80k indicate the company’s liabilities surpass total assets. This "balance sheet insolvency" is a serious condition, reflecting accumulated losses or poor capitalisation. It restricts the company's ability to raise capital and undermines creditor confidence.
Asset Base: Fixed assets have grown modestly but remain a small proportion of the overall financial structure. The company’s tangible asset base does not provide sufficient security against its obligations.
Growth and Scale: As a micro-entity operating in niche retail and manufacturing (cosmetics, perfumes, underwear), the company maintains a small scale with only two employees. Limited scale may constrain revenue generation and cash inflows, exacerbating liquidity issues.
Governance and Control: Two directors hold equal significant control (25-50% shares/voting rights), indicating concentrated ownership which can be beneficial for swift decision-making but may also limit external oversight.
4. Prognosis: Future Financial Outlook
Given current data, the company faces a high risk of insolvency if corrective measures are not taken promptly. Without an improvement in cash flow management, reduction of liabilities, or capital infusion, the symptoms suggest deteriorating financial health. The company’s survival depends on implementing a robust turnaround plan.
5. Recommendations: Actions to Improve Financial Wellness
Immediate Cash Flow Management:
- Negotiate extended payment terms with creditors to reduce short-term pressure.
- Accelerate receivables collection and optimize inventory to free up working capital.
Capital Restructuring:
- Consider capital injection from shareholders or external investors to restore positive equity.
- Explore debt refinancing to spread liabilities over a longer term and reduce immediate burden.
Cost Control:
- Review operational expenses rigorously to identify cost-saving opportunities.
- Assess employee and overhead costs aligned with business scale.
Strategic Business Review:
- Evaluate product mix and pricing strategy to improve margins.
- Assess market positioning to boost sales volume and revenue.
Financial Monitoring and Reporting:
- Implement regular financial health checks (monthly cash flow forecasts).
- Engage professional advice for restructuring or turnaround strategies.
Compliance and Governance:
- Maintain timely filing of accounts and returns (currently up to date).
- Ensure directors understand their duties in managing a company with financial difficulties.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.